The global biotechnology sector is undergoing a profound structural transformation, driven by the rapid convergence of artificial intelligence, high-throughput genomics,…
Read More
Varda Space Industries Secures $251m in Series D Funding to Pioneer Commercial In-Space Pharmaceutical Manufacturing
Varda Space Industries has successfully closed a massive $251m Series D financing round, bringing its cumulative venture backing to $598m…
Read More
Enveda Biosciences Secures $311m in Series E Funding to Accelerate AI-Powered Natural Drug Discovery Pipeline
Colorado-based biotechnology pioneer Enveda Biosciences has officially closed a substantial $311m Series E financing round, bringing its cumulative venture backing…
Read More
UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir
The National Institute for Health and Care Excellence (NICE) has issued a preliminary recommendation against the routine NHS commissioning of…
Read More
UK Life Sciences Sector Faces Funding Crisis Despite Government Prioritisation
The United Kingdom’s ambitious plans to foster growth within its vital life sciences sector are facing significant headwinds, with industry…
Read More
The Biotech Sector Navigates a Shifting Landscape of Funding, Regulation, and Innovation
Following a significant investment slump that began after the initial surge of capital during the early COVID-19 pandemic, the biotechnology…
Read More
SpliSense Advances Promising Cystic Fibrosis Therapy with Significant Funding and Phase IIb Trial Launch
The biotech firm SpliSense is making significant strides in the development of a novel therapy for cystic fibrosis, announcing a…
Read More
Europe Must Rethink Funding and De-Risk Assets to Secure its Rare Disease Research Pipeline
The 13th European Conference on Rare Diseases and Orphan Products, held in Prague, Czech Republic, from June 3-4, 2026, served…
Read More
Contraline Secures $92.5 Million in Series B Funding to Advance Reversible Male Contraceptive to Late-Stage Clinical Trials
Contraline, a pioneering biotechnology firm backed by Google Ventures, has successfully closed a substantial $92.5 million Series B financing round.…
Read More
Protuoso Biosciences Secures $9.5 Million Seed Funding to Pioneer Multifunctional Biologics for Complex Diseases
Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…
Read More
